Sudden cardiac death in non-ischemic dilated cardiomyopathy: A critical appraisal of existing and potential risk stratification tools

International Journal of Cardiology

Volumn 167, Issue 2, 2013, Pages 335-341

  Koutalas, Emmanuel ^a   Kanoupakis, Emmanuel ^a   Vardas, Panos ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Cardiac magnetic resonance; Genetic causes; Myocardial fibrosis; Non ischemic dilated cardiomyopathy; Sudden cardiac death risk stratification; Ventricular arrhythmogenesis

Indexed keywords

AMIODARONE; BISOPROLOL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOFETILIDE; GADOLINIUM; METOPROLOL; SPIRONOLACTONE;

ARRHYTHMOGENESIS; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MAGNETIC RESONANCE; CONGESTIVE CARDIOMYOPATHY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; ELECTROCARDIOGRAPHY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE FIBROSIS; HEART RATE TURBULENCE; HEART RATE VARIABILITY; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; IMAGE ENHANCEMENT; INCIDENCE; NONISCHEMIC CARDIOMYOPATHY; PRESSORECEPTOR REFLEX; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SUDDEN CARDIAC DEATH;

ANIMALS; CARDIOMYOPATHY, DILATED; DEATH, SUDDEN, CARDIAC; HUMANS; RISK ASSESSMENT; RISK FACTORS;

EID: 84879125031     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.07.014     Document Type: Review

References (86)

1. S.K. Huang, J.V. Messer, and P. Denes Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy: observations in 35 patients Am J Cardiol 51 1983 507 512
2. T. Meinertz, T. Hofmann, and W. Kasper Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy Am J Cardiol 53 1984 902 907
3. L. Eckhardt, G. Breithardt, and S. Hohnloser Ventricular tachycardia and sudden cardiac death A.J. Camm, T.F. Luescher, P.W. Serruys, The ESC textbook of cardiovascular medicine 2009 Oxford University Press Inc. New York, USA 1133 1171
4. R.E. Hershberger, J. Lindenfeld, L. Mestroni, C.E. Seidman, M.R. Taylor, and J.A. Towbin Heart Failure Society of America Genetic evaluation of cardiomyopathy - a Heart Failure Society of America practice guideline J Card Fail 15 2009 83 97
5. E.M. Kanoupakis, E.G. Manios, and E.M. Kallergis Serum markers of collagen turnover predict future shocks in implantable cardioverter- defibrillator recipients with dilated cardiomyopathy on optimal treatment J Am Coll Cardiol 55 2010 2753 2759
6. S. Nazarian, D.A. Bluemke, and A.C. Lardo Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy Circulation 112 2005 2821 2825
7. P. Richardson, W. McKenna, and M. Bristow Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies Circulation 93 1996 841 842
8. L. Mestroni, B. Maisch, and W.J. McKenna Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy Eur Heart J 20 1999 93 102
9. B.J. Maron, J.A. Towbin, and G. Thiene Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention Circulation 113 2006 1807 1816
10. S. Rakar, G. Sinagra, and A. Di Lenarda Epidemiology of dilated cardiomyopathy. A prospective post-mortem study of 5252 necropsies. The Heart Muscle Disease Study Group Eur Heart J 18 1997 117 123
11. M.K. Baig, J.H. Goldman, A.L. Caforio, A.S. Coonar, P.J. Keeling, and W.J. McKenna Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease J Am Coll Cardiol 31 1998 195 201
12. E. Grünig, J.A. Tasman, H. Kücherer, W. Franz, W. Kübler, and H.A. Katus Frequency and phenotypes of familial dilated cardiomyopathy J Am Coll Cardiol 31 1998 186 194
13. R.E. Hershberger, and J.D. Siegfried Update 2011: clinical and genetic issues in familial dilated cardiomyopathy J Am Coll Cardiol 57 2011 1641 1649
14. J.L. Jefferies, and J.A. Towbin Dilated cardiomyopathy Lancet 375 2010 752 762
15. N. De Leeuw, D.J. Ruiter, A.H.M.M. Balk, N. de Jonge, W.J.G. Melchers, and J.M.D. Galam Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy Transpl Int 14 2001 299 306
16. Z. Gunja-Smith, A.R. Morales, R. Romanelli, and J.F. Woessner Jr. Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinases and pyridinoline cross-links AJP 148 1996 1639 1648
17. Y. Nakayama, G. Shimizu, and Y. Hirota Functional and histopathologic correlation in patients with dilated cardiomyopathy: an integrated evaluation by multivariate analysis J Am Coll Cardiol 10 1987 186 192
18. K.R. Anderson, M.G. Sutton, and J.T. Lie Histopathological types of cardiac fibrosis in myocardial disease J Pathol 128 1979 79 85
19. Y.S. Lo, M. Billingham, R.A. Rowan, H.C. Lee, L.B. Liem, and C.D. Swerdlow Histopathologic and electrophysiologic correlations in idiopathic dilated cardiomyopathy and sustained ventricular tachyarrhythmia Am J Cardiol 64 1989 1063 1066
20. F.G. Akar, D.D. Spragg, R.S. Tunin, D.A. Kass, and G.F. Tomaselli Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy Circ Res 95 2004 717 725
21. T.J. Wu, J.J. Ong, and C. Hwang Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry J Am Coll Cardiol 3 1998 187 196
22. K. Soejima, W.G. Stevenson, J.L. Sapp, A.P. Selwyn, G. Couper, and L.M. Epstein Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars J Am Coll Cardiol 43 2004 1834 1842
23. H.H. Hsia, D.J. Callans, and F.E. Marchlinski Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia Circulation 108 2003 704 710
24. O. Cano, M. Hutchinson, and D. Lin Electroanatomic substrate and ablation outcome for suspected epicardial ventricular tachycardia in left ventricular nonischemic cardiomyopathy J Am Coll Cardiol 54 2009 799 808
25. S. Nakahara, R. Tung, and R.J. Ramirez Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy. Implications for catheter ablation of hemodynamically unstable ventricular tachycardia J Am Coll Cardiol 55 2010 2355 2365
26. G. Lopera, W.G. Stevenson, and K. Soejima Identification and ablation of three types of ventricular tachycardia involving the his- purkinje system in patients with heart disease J Cardiovasc Electrophysiol 15 2004 52 58
27. E.C.H. Keung, and R.S. Aronson Non-uniform properties and electrotonic interaction in hypertrophied rat myocardium Circ Res 49 1981 150 158
28. M.P. Pye, and S.M. Cobbe Arrhythmogenesis in experimental models of heart failure: the role of increased load Cardiovasc Res 32 1996 248 257
29. 2 + exchanger in end-stage human heart failure Circ Res 75 1994 443 453
30. J.L. Merino Mechanisms underlying ventricular arrhythmias in idiopathic dilated cardiomyopathy: implications for management Am J Cardiovasc Drugs 1 2001 105 118
31. M. Packer, A.J. Coats, and M.B. Fowler Effect of carvedilol in severe chronic heart failure N Engl J Med 344 2001 1651 1658
32. MERIT-HF Study Group Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized Intervention trial in congestive heart failure (MERIT-HF) Lancet 353 1999 2001 2007
33. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial Lancet 353 1999 9 13
34. H.C. Doval, D.R. Nul, and H.O. Grancelli For Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA): randomized trial of low-dose amiodarone in severe congestive heart failure Lancet 344 1994 493 498
35. S.N. Singh, R.D. Fletcher, and S.G. Fisher Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival trial of antiarrhythmic therapy in congestive heart failure N Eng J Med 333 1995 77 82
36. C. Torp-Pedersen, M. Møller, and P.E. Bloch-Thomsen Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish investigations of arrhythmia and mortality on Dofetilide Study Group N Eng J Med 341 1999 857 865
37. G.H. Bardy, K.L. Lee, and D.B. Mark Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) investigators: amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Eng J Med 352 2005 225 237
38. P. Jong, C. Demers, R.S. McKelvie, and P.P. Liu Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials J Am Coll Cardiol 39 2002 463 470
39. B. Pitt, F. Zannad, and W.J. Remme The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717
40. A.E. Epstein, J.P. DiMarco, and K.A. Ellenbogen American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons J Am Coll Cardiol 51 2008 e1 e62
41. D.L. Packer, J.M. Prutkin, and A.S. Hellkamp Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial Circulation 120 2009 2170 2176
42. A. Kadish, A. Dyer, and J.P. Daubert Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) investigators prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med 350 2004 2151 2158
43. R. Tung, P. Zimetbaum, and M.E. Josephson A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death J Am Coll Cardiol 52 2008 1111 1121
44. M.R. Bristow, L.A. Saxon, and J. Boehmer Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) investigators cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
45. J.G. Cleland, J.C. Daubert, and E. Erdmann Cardiac Resynchronization- Heart Failure (CARE-HF) study investigators: the effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
46. J.G. Cleland, J.C. Daubert, and E. Erdmann Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase] Eur Heart J 27 2006 1928 1932
47. P. Carson, I. Anand, and C. O'Connor Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial J Am Coll Cardiol 46 2005 2329 2334
48. M.R. Gold, C. Linde, W.T. Abraham, A. Gardiwal, and J.C. Daubert The impact of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in mild heart failure Heart Rhythm 8 2011 679 684
49. D.P. Zipes, A.J. Camm, and M. Borggrefe American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society: ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace 8 2006 746 783
50. G.W. Dec, and V. Fuster Idiopathic dilated cardiomyopathy N Engl J Med 331 1994 1564 1575
51. S.A. Strickberger, J.D. Hummel, and T.G. Bartlett AMIOVIRT investigators: amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia - AMIOVIR J Am Coll Cardiol 41 2003 1707 1712
52. W. Grimm, M. Christ, J. Bach, H.H. Müller, and B. Maisch Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study Circulation 108 2003 2883 2891
53. D. Bänsch, M. Antz, and S. Boczor Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT) Circulation 105 2002 1453 1458
54. W. Whang, M.A. Mittleman, and D.Q. Rich Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study Circulation 109 2004 1386 1391
55. J.J. Goldberger, M.E. Cain, and S.H. Hohnloser American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. American Heart Association; American College of Cardiology Foundation; Heart Rhythm Society Circulation 118 2008 1497 1518
56. H.R. Middlekauff, W.G. Stevenson, L.W. Stevenson, and L.A. Saxon Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope J Am Coll Cardiol 21 1993 110 116
57. B. Brembilla-Perrot, C. Suty-Selton, and D. Beurrier Differences in mechanisms and outcomes of syncope in patients with coronary disease or idiopathic left ventricular dysfunction as assessed by electrophysiologic testing J Am Coll Cardiol 44 2004 594 601
58. B. Olshansky, J.E. Poole, and G. Johnson Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study J Am Coll Cardiol 51 2008 1277 1282
59. R.S. Phang, D. Kang, H. Tighiouart, N.A.M. Estes, and M.S. Link High risk of ventricular arrhythmias in patients with nonischemic dilated cardiomyopathy presenting with syncope Am J Cardiol 97 2006 416 420
60. J.P. Daubert, S.L. Winters, and H. Subacius Defibrillators In Nonischemic Cardiomyopathy Treatment Evaluation (DEFINITE) investigators: ventricular arrhythmia inducibility predicts subsequent ICD activation in nonischemic cardiomyopathy patients: a DEFINITE substudy Pacing Clin Electrophysiol 32 2009 755 761
61. E.S. Brilakis, P.A. Friedman, and T.N. Maounis Programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and syncope receiving implantable cardioverter-defibrillators: a case series and a systematic review of the literature Int J Cardiol 98 2005 395 401
62. A.D. Desai, T.S. Yaw, T. Yamazaki, A. Kaykha, S. Chun, and V.F. Froelicher Prognostic significance of quantitative QRS duration Am J Med 119 2006 600 606
63. S. Baldasseroni, C. Opasich, and M. Gorini Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure Am Heart J 143 2002 398 405
64. S. Iuliano, S.G. Fisher, P.E. Karasik, R.D. Fletcher, and S.N. Singh Department of Veterans Affairs Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. QRS duration and mortality in patients with congestive heart failure Am Heart J 143 2002 1085 1091
65. M. Iacoviello, C. Forleo, and P. Guida Ventricular repolarization dynamicity provides independent prognostic information toward major arrhythmic events in patients with idiopathic dilated cardiomyopathy J Am Coll Cardiol 50 2007 225 231
66. M.K. Das, W. Maskoun, and C. Shen Fragmented QRS on twelve-lead electrocardiogram predicts arrhythmic events in patients with ischemic and nonischemic cardiomyopathy Heart Rhythm 7 2010 74 80
67. M. Zecchin, A. Di Lenarda, and D. Gregori Are nonsustained ventricular tachycardias predictive of major arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment? Pacing Clin Electrophysiol 31 2008 290 299
68. M. Sysi-Aho, J. Koikkalainen, and T. Seppänen-Laakso Serum lipidomics meets cardiac magnetic resonance imaging: profiling of subjects at risk of dilated cardiomyopathy MPLoS One 6 2011 e15744
69. C. Meune, J.H. Van Berlo, F. Anselme, G. Bonne, Y.M. Pinto, and D. Duboc Primary prevention of sudden death in patients with lamin A/C gene mutations N Engl J Med 354 2006 209 210
70. M. Pasotti, C. Klersy, and A. Pilotto Long-term outcome and risk stratification in dilated cardiolaminopathies J Am Coll Cardiol 52 2008 1250 1260
71. C. Jellis, J. Martin, J. Narula, and T.H. Marwick Assessment of nonischemic myocardial fibrosis J Am Coll Cardiol 56 2010 89 97
72. G. Klappacher, P. Franzen, and D. Haab Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis Am J Cardiol 75 1995 913 918
73. T. Ohtsuka, K. Nishimura, A. Kurata, A. Ogimoto, H. Okayama, and J. Higaki Serum matrix metalloproteinase-3 as a novel marker for risk stratification of patients with nonischemic dilated cardiomyopathy J Cardiac Fail 13 2007 752 758
74. E. Picano, G. Pelosi, and M. Marzilli In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans Circulation 81 1990 58 64
75. D. Neglia, C. Michelassi, and M.G. Trivieri Prognostic role on myocardial blood flow impairment in idiopathic left ventricular dysfunction Circulation 105 2002 186 193
76. R.J. Kim, D.P. Shah, and R.M. Judd How we perform delayed enhancement imaging J Cardiovasc Magn Reson 5 2003 505 514
77. J.A. McCrohon, J.C. Moon, and S.K. Prasad Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance Circulation 108 2003 54 59
78. R.G. Assomull, S.K. Prasad, and J. Lyne Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy J Am Coll Cardiol 48 2006 1977 1985
79. K.C. Wu, R.G. Weiss, and D.R. Thiemann Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy J Am Coll Cardiol 51 2008 2414 2421
80. V. Hombach, N. Merkle, and J. Torzewski Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy Eur Heart J 30 2009 2011 2018
81. M. Yokokawa, H. Tada, and K. Koyama The characteristics and distribution of the scar tissue predict ventricular tachycardia in patients with advanced heart failure Pacing Clin Electrophysiol 32 2009 314 322
82. A.K. Kono, K. Ishii, H. Kumagai, Y. Taniguchi, T. Kajiya, and K. Sugimura Late gadolinium enhancement on cardiac magnetic resonance imaging: is it associated with a higher incidence of nonsustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy? Jpn J Radiol 28 2010 355 361
83. J.L. Looi, C. Edwards, and G.P. Armstrong Characteristics and prognostic importance of myocardial fibrosis in patients with dilated cardiomyopathy assessed by contrast-enhanced cardiac magnetic resonance imaging Clin Med Insights Cardiol 4 2010 129 134
84. P.G. Masci, A. Barison, and F.D. Aquaro Myocardial delayed enchancement in paucisymptomatic nonischemic dilated cardiomyopathy Int J Cardiol 5 Dec 20 2010 71 73
85. L. Iles, H. Pfluger, and L. Lefkovits Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter- defibrillators for primary prevention of sudden cardiac death J Am Coll Cardiol 57 2011 821 828
86. S. Lehrke, D. Lossnitzer, and M. Schöb Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy Heart 97 2011 727 732